Abstract
Aims:
The present study aimed to search for novel potent inhibitor(s) against the recently discovered maltosyltransferase (GlgE) target of M.tb.
Background:
GlgE belongs to an α-amylase family and catalyzes the elongation of cytosolic branched α-glucan. Inactivation of M.tb.GlgE results in DNA damage and rapid death of M.tb. due to the accumulation of a toxic altosyl donor, maltose-1-phosphate (M1P), suggesting that GlgE is an intriguing target for inhibitor design.
Method:
1000 natural compounds were compiled from public databases and literature through virtual screening, of which 25 compounds were found to satisfy all drug-likeness properties and ADME/toxicity criteria, followed by molecular docking with GlgE. Compound(s) showing the lowest binding energy was further subjected to molecular dynamics simulation (MDS) and in vitro analysis.
Results:
Molecular docking analysis allowed the selection of 5 compounds showing significant binding affinity to GlgE targets. Amongst these compounds, asiatic acid exhibited the lowest binding energy (-12.61 kcal/mol). The results of 20-ns MDS showed that asiatic acid formed a stable complex with GlgE. Additionally,asiatic acid exhibited in vitro anti-mycobacterial activity against M.tb. H37Ra, M. bovisBCG, and M. smegmatisstrains.
Conclusion:
The study reveals Asiatic acid as a promising anti-mycobacterial agent that might emerge as a novel natural anti-TB lead in the future.
Full text
